γ-Irradiated cord blood MNCs: Different paracrine effects on mature and progenitor endothelial cells

Microvascular Research

Volumn 94, Issue , 2014, Pages 9-16

  Cervio, Marila ^a   Scudeller, Luigia ^a   Viarengo, Gianluca ^a   Monti, Manuela ^a   Del Fante, Claudia ^a   Arici, Vittorio ^a   Perotti, Cesare ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Conditioned medium; Cord blood; Endothelial cells; Endothelial progenitor cells; Mononuclear cells; Neovascularization

Indexed keywords

EPIDERMAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AB; VASCULOTROPIN; CULTURE MEDIUM;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BLOOD RADIATION; CAPILLARY; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CORD BLOOD DERIVED MONONUCLEAR CELL; CULTURE MEDIUM; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONONUCLEAR CELL; NEOVASCULARIZATION (PATHOLOGY); PARACRINE SIGNALING; PRIORITY JOURNAL; REGENERATIVE MEDICINE; UMBILICAL CORD BLOOD; UMBILICAL VEIN ENDOTHELIAL CELL; CELL MOTION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; ENDOTHELIUM CELL; FETUS BLOOD; GAMMA RADIATION; PHENOTYPE; RADIATION RESPONSE; REGENERATION; STEM CELL; TIME;

APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FETAL BLOOD; GAMMA RAYS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; REGENERATION; STEM CELLS; TIME FACTORS;

EID: 84904670029     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2014.04.009     Document Type: Article

References (40)

1. Abdelwahid E., et al. Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications. Curr. Cardiol. Rev. 2011, 7:201-212.
2. Ankersmit H.J., et al. Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium. Eur. J. Clin. Invest. 2009, 39:445-456.
3. Asahara T., et al. Concise review: circulating endothelial progenitor cells for vascular medicine. Stem Cells 2011, 29:1650-1655.
4. Attanasio S., Snell J. Therapeutic angiogenesis in the management of critical limb ischemia: current concepts and review. Cardiol. Rev. 2009, 17:115-120.
5. Au P., et al. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 2008, 111:1302-1305.
6. Blum A., et al. Advances in cell-based therapy for peripheral vascular disease. Atherosclerosis 2012, 223:269-277.
7. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 2003, 9:653-660.
8. Di Santo S., et al. Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation. PLoS One 2009, 4:e5643.
9. Fast L.D. Developments in the prevention of transfusion-associated graft-versus-host disease. Br. J. Haematol. 2012, 158:563-568.
10. Gluckman E. Milestones in umbilical cord blood transplantation. Blood Rev. 2011, 25:255-259.
11. Gnecchi M., et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 2008, 103:1204-1219.
12. Heeschen C., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004, 109:1615-1622.
13. Hoetzenecker K., et al. Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation. Basic Res. Cardiol. 2012, 107:292.
14. Hung S.C., et al. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 2007, 25:2363-2370.
15. Ingram D.A., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104:2752-2760.
16. Isner J.M., Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J. Clin. Invest. 1999, 103:1231-1236.
17. Janowska-Wieczorek A., et al. Autocrine/paracrine mechanisms in human hematopoiesis. Stem Cells 2001, 19:99-107.
18. Korf-Klingebiel M., et al. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur. Heart J. 2008, 29:2851-2858.
19. Lasala G.P., Minguell J.J. Vascular disease and stem cell therapies. Br. Med. Bull. 2011, 98:187-197.
20. Lavergne M., et al. Cord blood-circulating endothelial progenitors for treatment of vascular diseases. Cell Prolif. 2011, 44(Suppl. 1):44-47.
21. Lawall H., et al. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb. Haemost. 2010, 103:696-709.
22. Lichtenauer M., et al. Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction. Basic Res. Cardiol. 2011, 106:645-655.
23. Lichtenauer M., et al. Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study. Basic Res. Cardiol. 2011, 106:1283-1297.
24. Lloyd-Jones D., et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010, 121:e46-e215.
25. Majka M., et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001, 97:3075-3085.
26. Mead L.E., Prater D., Yoder M.C., Ingram D.A. Isolation and characterization of endothelial progenitor cells from human blood. Curr Protoc Stem Cell Biol. 2008/09/05 ed 2008, John Wiley & Sons, Inc., p. Unit 2C 1. http://dx.doi.org/10.1002/9780470151808.sc02c01s6.
27. Mirotsou M., et al. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J. Mol. Cell. Cardiol. 2011, 50:280-289.
28. Mitsos S., et al. Therapeutic angiogenesis for myocardial ischemia revisited: basic biological concepts and focus on latest clinical trials. Angiogenesis 2012, 15:1-22.
29. Perotti C., et al. Allogeneic lethally irradiated cord blood mononuclear cells in no-option critical limb ischemia: a "box of rain". Stem Cells Dev 2013, 22:2806-2812.
30. Piaggio G., et al. Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker. Blood 2009, 114:3127-3130.
31. Ratajczak J., et al. Paracrine proangiopoietic effects of human umbilical cord blood-derived purified CD133+ cells-implications for stem cell therapies in regenerative medicine. Stem Cells Dev. 2013, 22:422-430.
32. Raval Z., Losordo D.W. Cell therapy of peripheral arterial disease: from experimental findings to clinical trials. Circ. Res. 2013, 112:1288-1302.
33. Roura S., et al. Umbilical cord blood for cardiovascular cell therapy: from promise to fact. Ann. N. Y. Acad. Sci. 2012, 1254:66-70.
34. Sahoo S., et al. Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circ. Res. 2011, 109:724-728.
35. Silvestre J.S. Pro-angiogenic cell-based therapy for the treatment of ischemic cardiovascular diseases. Thromb. Res. 2012, 130(Suppl. 1):S90-S94.
36. Sprengers R.W., et al. Progenitor cell therapy in patients with critical limb ischemia without surgical options. Ann. Surg. 2008, 247:411-420.
37. Thum T., et al. The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J. Am. Coll. Cardiol. 2005, 46:1799-1802.
38. Tongers J., et al. Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. Microvasc. Res. 2010, 79:200-206.
39. Yang Z., et al. Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells. Atherosclerosis 2010, 211:103-109.
40. Zhang Y., et al. Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H1675-H1682.